CD8A and breast cancer: The above results indicated that 4-OHA could significantly promote the infiltration of immune cells into DMBA-induced mammary tumors, but with some differences between the two formulations, such as there were more active CD8+ T cells, immature DCs, and Th17 cells in the 4-OHA injection group than in the 4-OHA cream group.